2024
DOI: 10.1186/s13045-024-01647-1
|View full text |Cite
|
Sign up to set email alerts
|

Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives

Yuhang Chen,
Suoyi Dai,
Chien-shan Cheng
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 241 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?